OTS

OTS, Caltrans Release New "Go Safely" Public Service Announcement

Retrieved on: 
Tuesday, October 11, 2022
Public Transport, Other Transport, Technology, Other Communications, Transport, Communications, Media, Audio, Video, Vacation, Travel, Element, Distracted driving, We as Human discography, California Department, Pedestrian, Walking, OTS, Road traffic safety, California Office of Environmental Health Hazard Assessment, PSAS, Death, Crash, Radio, Ridesharing company, Road, California Department of Transportation

The California Office of Traffic Safety (OTS) and California Department of Transportation (Caltrans) released a new Go Safely public service announcement emphasizing the outsized role drivers play in keeping themselves and others on the road safe.

Key Points: 
  • The California Office of Traffic Safety (OTS) and California Department of Transportation (Caltrans) released a new Go Safely public service announcement emphasizing the outsized role drivers play in keeping themselves and others on the road safe.
  • Initially launched in 2018, "Go Safely, California" is a comprehensive education and encouragement campaign that places a top priority on safe travel habits.
  • No longer can we as a society accept traffic deaths as routine, said Caltrans Director Tony Tavares.
  • Roger Luas winning video landed him a role in the new PSAs, which were filmed last month in Sacramento.

Cybersecurity and US FDA Requirements Webinar: How Cybersecurity is Introduced into the CGMPs, Design Control (21 CFR 820.30) for Devices, and Post-production by the CAPA System - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 6, 2022
Software, Technology, Internet, Security, Prevalence, Computer, Growth, Health Insurance Portability and Accountability Act, CGMP-specific phosphodiesterase type 5, HIPAA, CAPA, OTS, General Data Protection Regulation, CFR, CGMP, Update, GDPR, Medical device, Accountability Act, Record, FDA, Title 21 CFR Part 11, Hacking, Compliance, Documentation, Computer security, Industry, Agency, EU

There are regulations such as 21 CFR Part 11 in the U.S. and Annex 11 in Europe.

Key Points: 
  • There are regulations such as 21 CFR Part 11 in the U.S. and Annex 11 in Europe.
  • The FDA and news media have emphasized the prevalence of cybersecurity issues, such as data/identity theft, and hacking which pose hazards to many activities and businesses/industries.
  • The US also has the Health Insurance Portability and Accountability Act of 1996 (HIPAA) requirements for patient data protections.
  • This webinar will consider how cybersecurity is introduced into the CGMPs, design control (21 CFR 820.30) for devices, and post-production by the CAPA system, among others.

Wave Life Sciences to Highlight Advancements from PRISM Platform at Upcoming Scientific Congresses

Retrieved on: 
Monday, October 3, 2022
RNA interference, Congress, Wave, Aimer, Private Securities Litigation Reform Act, ESGCT, Annual report, MDT, Oligonucleotide, Enzyme, Gene, Tissue, Genome, Research, AATD, PS, BST, Patient, Biochemistry, Pharmacology, Medicinal chemistry, Gene silencing, Doctor of Philosophy, SEC, PRISM, RNA, Cell, Risk, GLOBE, Inosine, Chemistry, Guanine, Drug development, European Society of Gene and Cell Therapy, Gene expression, ADAR, Adenine, List of life sciences, OTS, PN, Efficiency, Liposome, Senior, Medical imaging, Phosphorus, Communications satellite, Fine chemical, Vaccine

CAMBRIDGE, Mass., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced it will highlight oligonucleotide chemistry advancements from the company’s PRISMTM discovery and drug development platform at upcoming scientific conferences. The company will also highlight its A-to-I RNA base editing oligonucleotides (AIMers), including WVE-006 for alpha-1 antitrypsin deficiency (AATD), as well as its RNA interference (RNAi) capabilities. The scientific congresses include the 18th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS), taking place October 2-5, 2022, and the European Society of Gene & Cell Therapy 29th Congress (ESGCT), taking place October 11-14, 2022.

Key Points: 
  • Our data at OTS and ESGCT are illustrative of both the evolution and the potential of Waves science, said Chandra Vargeese, PhD, Chief Technology Officer and Head of Platform Discovery Sciences at Wave Life Sciences.
  • PRISM is Wave Life Sciences proprietary discovery and drug development platform that enables genetically defined diseases to be targeted with stereopure oligonucleotides across multiple therapeutic modalities, including silencing, splicing, and editing.
  • Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases.
  • Wave undertakes no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances.

The Non-Clinical PT Unveils Its Strategic Approach to Facilitate Career Changes for Clinicians

Retrieved on: 
Monday, September 19, 2022
OT, Occupational burnout, Nursing, Knowledge, WebPT, OTS, Health, News, Growth, PTS, Optimism, Physician, SLP, PT, Student, Anatomical pathology, Interview, Rehabilitation, Occupational therapy, Walnut, Education, Medicine

Walnut, California--(Newsfile Corp. - September 19, 2022) - The Non-Clinical PT has unveiled its strategic approach to help clinicians find new meaning in their careers.

Key Points: 
  • Walnut, California--(Newsfile Corp. - September 19, 2022) - The Non-Clinical PT has unveiled its strategic approach to help clinicians find new meaning in their careers.
  • Meredith Castin founded The Non-Clinical PT to address the challenges and stigma she faced when attempting to launch her own non-clinical career.
  • The Non-Clinical PT, founded by Meredith Castin, has helped thousands of rehabilitation professionals seeking career growth beyond direct patient care.
  • The Non-Clinical PT takes pride in its unwavering commitment to helping its students excel in all their career aspirations and endeavors.

EXFO accelerates 'lab to live' for next-generation optics with new, innovative test solutions

Retrieved on: 
Thursday, September 15, 2022
Software, Programmable interrupt controller, Die (integrated circuit), Laser, 262, ECOC, OTS, CCgroup, Booth, News, OIF, Industry, PCM, PON, EXFO, Ethernet Alliance, Solution, Fiber to the x, Telecommunications equipment, Printed circuit board, Online shopping

QUEBEC CITY, Sept. 15, 2022 /PRNewswire/ -- EXFO, the communications industry's test, monitoring and analytics experts, today announced availability of a next-generation continuously tunable laser -- the first in a new suite of tunable lasers designed to deliver cost-optimized testing of transceivers and optical components in high-volume manufacturing. The T200S tunable laser is part of EXFO's line-up of innovative, next-generation solutions that will be showcased during ECOC 2022, the premiere manufacturing, design, and research trade show upcoming in Basel, Switzerland Sept. 18-22.

Key Points: 
  • EXFO's new T200S tunable laser is half the size and operates 2x as fast as previous tunable laser models.
  • EXFO is unique in the industry, offering both passive and active component testing.
  • Testing module for coherent optics (CFP2-DCO): This module covers testing needs for 400/800GbE and next-generation transceivers, leveraging EXFO's open transceiver system (OTS).
  • EXFO develops smarter test, monitoring and analytics solutions for the global communications industry.

ZOLEO Wins UK Outdoor Industry Award

Retrieved on: 
Wednesday, September 14, 2022
Wi-Fi, Safety, Autobarn Racing, Recreation, OTS, Tech, REI, Bluetooth, MEC, SBD, Anaconda, SOS, Work, General manager, Dalesman, Association, GLOBE, Wi-Fi Alliance, OIA, GPS, Mobile phone, Iridium

TORONTO, Sept. 14, 2022 (GLOBE NEWSWIRE) -- ZOLEO Inc., an emerging global messaging solutions company, announced its ZOLEO global satellite communicator has garnered the top 2022 Tech Accessories Award by the UK Outdoor Industry Association (OIA).

Key Points: 
  • TORONTO, Sept. 14, 2022 (GLOBE NEWSWIRE) -- ZOLEO Inc., an emerging global messaging solutions company, announced its ZOLEO global satellite communicator has garnered the top 2022 Tech Accessories Award by the UK Outdoor Industry Association (OIA).
  • The judging panel, comprised of outdoor industry experts and key journalists and retailers, selected finalists in each of the ten categories at the Outdoor Tradeshow (OTS) in June.
  • The UK Outdoor Industry Awards recognise innovation and leading-edge technology in several different product categories in the outdoor market and aim to reward brands that push the boundaries to bring the best products to consumers in the outdoor market, said Marta Williams, Head of Operations for the Outdoor Industries Association.The Tech Accessories category showcased top outdoor gadgets including sport watches, GPS, cameras and apps.
  • The UK Outdoor Industry Awards is an initiative launched by the Outdoor Industries Association.

Education Resources, Inc. Announces New, On-Demand, Online Continuing Education Course with Amanda Hall, PT, MPT, PCS

Retrieved on: 
Tuesday, September 13, 2022
Adult, Neuro, PCS, MPT, Person-centered therapy, Gait, Knowledge, OTS, PTS, Foot, Open educational resources, Patient, Walking, PT, I Ran (So Far Away), ERI, Hall, Research, Multimedia, Education, Therapy, Activity, Medicine, Online shopping, Ankle

BOSTON, Sept. 13, 2022 /PRNewswire/ -- Education Resources, Inc., a leading continuing education provider for physical therapists, occupational therapists, and speech-language pathologists, is adding to the company's robust online, on-demand course catalog with: Ambulation, Activity and AFOs: Addressing the Ankle to Improve Gait and Function-ONLINE.

Key Points: 
  • The online course, which is now available through ERI's website , was previously recorded during a live webinar and can now be taken from the convenience of home or office.
  • Here's what one therapist has said about Ambulation, Activity and AFOs: Addressing the Ankle to Improve Gait and Function:
    Amanda is wonderful.
  • One thing I found particularly helpful is applying concepts to interventions you can use in clinic next week following the course.
  • Education Resources, Inc. (ERI) is an accredited provider of continuing education that helps PTs, OTs, and SLPs transform the lives of their patients.

American Technologies Network (ATN) Announces Partnership with "Pigman" to Kick Off Hog Hunting Season

Retrieved on: 
Thursday, September 8, 2022
Partnership, Technology, Thor, Eurosport 1, YouTube, Personality, Night vision, OTS, Sportsman, Instagram, ATN, Industry, Nature, Sport, Telescopic sight, Pigman, Facebook

ATN said this is an important and exciting partnership for the company because Pigman is a longtime ATN customer favorite.

Key Points: 
  • ATN said this is an important and exciting partnership for the company because Pigman is a longtime ATN customer favorite.
  • With more brick-and-mortar ATN locations opening and hog season right around the corner, ATN's timely partnership with widely popular "Pigman" offers the perfect synergy for hog hunting and ATN brand enthusiasts alike.
  • "We'll be working closely with Pigman , incorporating his input on new product development and releases," ATN Founder Marc Vayn said.
  • American Technology Network is an innovative industry leader and manufacturer of night vision and thermal Smart Optics products.

The Oligonucleotide Therapeutics Society's Highly Anticipated Annual Meeting Returns in Person This Year

Retrieved on: 
Sunday, September 4, 2022
Proceedings of the Human Factors and Ergonomics Society Annual Meeting, University, Research, Genome-wide CRISPR-Cas9 knockout screens, RNA, Cancer, Founder, University of North Carolina at Greensboro, Degenerative disease, Therapy, SAN, Doctor of Philosophy, Lessons learned, OTS, Intellia Therapeutics, Senior, Hearing, Chemistry, Goal, Student, Genome, Peak, Alzheimer's disease, Alnylam Pharmaceuticals, GLOBE, Oligonucleotide, Annual general meeting, Board of directors, Silence Therapeutics, Ionis Pharmaceuticals, COVID-19, RNA transfection, Society, ALS, Pharmaceutical industry, MD

The Oligonucleotide Therapeutics Society (OTS) is an open, nonprofit forum to foster academic and industry-based research and development of oligonucleotide therapeutics.

Key Points: 
  • The Oligonucleotide Therapeutics Society (OTS) is an open, nonprofit forum to foster academic and industry-based research and development of oligonucleotide therapeutics.
  • The OTS Annual Meeting is a forum for the realization of the Society's mission and goals.
  • Speakers include notable authorities in the field at key roles in Biogen, Ionis Pharmaceuticals, Alnylam Pharmaceuticals, Intellia Therapeutics, Silence Therapeutics, and n-Lorem Foundation.
  • The Annual Meeting is open to anyone interested or involved in oligonucleotide therapeutics.

CURE Pharmaceutical Announces Rob Davidson as new Chairman of the Board and Appointment of Rob Costantino as Member of the Board and Audit Committee Chairman

Retrieved on: 
Tuesday, August 16, 2022
U.S. Securities and Exchange Commission, CEO, GLOBE, SVP, SEC, Board, Security (finance), Annual report, Communication, Instagram, Beauty, COO, Health, DTC, Industry, CFO, Technology, Ministry of Health & Wellness, Sale, Director, Patent, CURE, Volvo, Safety, Our Boarding House, Forward-looking statement, Audit, Growth, Merrill (company), Zicam, Wells Fargo, Time, Innovation, Negotiation, NYSE, Professional Football Compensation Committee, OTS, Company, Twitter, OTC, CPA, NASDAQ, Private Securities Litigation Reform Act, Management, Facebook, Wachovia, Wachovia

OXNARD, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) -- CURE Pharmaceutical Holding Corp. (OTC: CURR) (“CURE”), a proprietary platform technology company, today announced the appointment of former CEO Rob Davidson to Chairman of the Board of Directors. In addition, the Company announced the appointment of Robert J. Costantino to its board of directors and he has also been appointed as the Chairman of CURE’s Audit Committee. These appointments bring decades of financial experience, as well as continuity that should enhance the company’s shareholder value initiatives and communications.

Key Points: 
  • OXNARD, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) -- CURE Pharmaceutical Holding Corp. (OTC: CURR) (CURE), a proprietary platform technology company, today announced the appointment of former CEO Rob Davidson to Chairman of the Board of Directors.
  • In addition, the Company announced the appointment of Robert J. Costantino to its board of directors and he has also been appointed as the Chairman of CUREs Audit Committee.
  • Rob Davidson was most recently CUREs Chief Executive Officer from July 2011 to July 2022 and served as Chairman of our Board until January 2019.
  • Mr. Davidson was responsible for the development of several drug delivery technologies and commercial brand extensions.